ArticleClinical trials (London, England)2021
On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomes.
Michelle M Nuño et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it